Holen Sie sich die Stockscreener-App
3.25
0.00%
0.00
Handel nachbörslich:
3.25
Schlusskurs vom Vortag:
$3.25
Offen:
$3.22
24-Stunden-Volumen:
252.69K
Relative Volume:
0.72
Marktkapitalisierung:
$257.91M
Einnahmen:
$351.37M
Nettoeinkommen (Verlust:
$-174.01M
KGV:
-1.57
EPS:
-2.07
Netto-Cashflow:
$-126.94M
1W Leistung:
+0.00%
1M Leistung:
+12.07%
6M Leistung:
+9.06%
1J Leistung:
-1.22%
1-Tages-Spanne:
$3.15
$3.26
1-Wochen-Bereich:
$3.15
$3.335
52-Wochen-Spanne:
$2.455
$4.02
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
Firmenname
Atea Pharmaceuticals Inc
Sektor
Branche
Telefon
857-204-8109
Adresse
225 FRANKLIN STREET, BOSTON
Vergleichen Sie AVIR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.25 | 257.91M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-10-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-24 | Eingeleitet | JP Morgan | Overweight |
| 2020-11-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Atea Pharmaceuticals Inc Aktie (AVIR) Neueste Nachrichten
Is Atea Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 EndofMonth & Verified Technical Signals - newser.com
Backtesting results for Atea Pharmaceuticals Inc. trading strategiesEarnings Beat & Risk Managed Investment Entry Signals - newser.com
Is a relief rally coming for Atea Pharmaceuticals Inc. holdersJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
Live market analysis of Atea Pharmaceuticals Inc.July 2025 Fed Impact & Community Shared Stock Ideas - newser.com
Atea Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Reactions & High Conviction Investment Ideas - newser.com
Is Atea Pharmaceuticals Inc. still worth holding after the dipBuy Signal & Consistent Return Investment Signals - newser.com
Key metrics from Atea Pharmaceuticals Inc.’s quarterly dataJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
Is Atea Pharmaceuticals Inc. stock cheap at current valuation2025 Market Overview & High Accuracy Swing Entry Alerts - newser.com
Atea Pharmaceuticals, Inc. (AVIR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Atea Pharmaceuticals Advances with Key Phase 1 Study on Bemnifosbuvir/Ruzasvir - MSN
Atea Pharmaceuticals Inc Stock Analysis and ForecastFlag and Pennant Patterns & Outstanding Portfolio Growth - earlytimes.in
Atea Pharmaceuticals, Inc. (AVIR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Atea Pharmaceuticals (AVIR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Applying sector rotation models to Atea Pharmaceuticals Inc.Weekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - newser.com
Using economic indicators to assess Atea Pharmaceuticals Inc. potentialMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
What drives Atea Pharmaceuticals Inc stock priceDividend Reinvestment Plans & Free Fastest Return On Investment - earlytimes.in
Will Atea Pharmaceuticals Inc. stock split attract more investorsIPO Watch & Daily Profit Maximizing Trade Tips - fcp.pa.gov.br
Will Atea Pharmaceuticals Inc. stock continue dividend increasesWeekly Trading Summary & Reliable Entry Point Alerts - fcp.pa.gov.br
Atea Pharmaceuticals’ New HCV Study: Potential Game-Changer? - TipRanks
Atea Pharmaceuticals’ Promising HCV Treatment Study: Key Insights for Investors - TipRanks
Custom strategy builders for tracking Atea Pharmaceuticals Inc.Dollar Strength & Capital Efficiency Focused Ideas - newser.com
Finanzdaten der Atea Pharmaceuticals Inc-Aktie (AVIR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):